- Home
- ESTA vs MIST Comparison
ESTA vs MIST Comparison
Compare ESTA & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ESTA | MIST |
|---|---|---|
| Founded | 2004 | 2003 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 176.3M |
| IPO Year | 2018 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ESTA | MIST |
|---|---|---|
| Price | $59.03 | $1.61 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 4 |
| Target Price | ★ $86.86 | $8.50 |
| AVG Volume (30 Days) | 448.5K | ★ 2.2M |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 42.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $61,208,000.00 | N/A |
| Revenue This Year | $28.01 | $2,915.14 |
| Revenue Next Year | $26.20 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 76.49 | N/A |
| 52 Week Low | $26.56 | $0.63 |
| 52 Week High | $83.31 | $3.06 |
Technical Indicators
Market Signals| Indicator | ESTA | MIST |
|---|---|---|
| Relative Strength Index (RSI) | 41.43 | 55.48 |
| Support Level | $36.41 | $1.43 |
| Resistance Level | $68.38 | $1.78 |
| Average True Range (ATR) | 3.47 | 0.14 |
| MACD | 0.21 | 0.04 |
| Stochastic Oscillator | 47.41 | 76.16 |
Price Performance
Historical ComparisonAbout ESTA Establishment Labs Holdings Inc.
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).